Alvotech and STADA add to strategic alliance through denosumab partnership
12 Jun 2024 //
PRESS RELEASE
Sustained Renal Function Improvements In Hypoparathyroidism With TransCon PTH
13 May 2024 //
GLOBENEWSWIRE
Radius Presents TYMLOS (abaloparatide) Data at World Osteoporosis, OA Congress
16 Apr 2024 //
ACCESSWIRE
Ambio Announces US FDA Approval of a Generic Version of Forteo
01 Dec 2023 //
BUSINESSWIRE
Apotex Corp. Launches Teriparatide Injectable for Osteoporosis Treatment
21 Nov 2023 //
PR NEWSWIRE
Teva Announces Approval of a Generic Version of Forteo, in the U.S.
17 Nov 2023 //
BUSINESSWIRE
Apotex`s Generic Teriparatide Receives Approval in the U.S.
16 Nov 2023 //
FDA
Strides Pharma`s Kauliv (teriparatide) Receives Approval in Europe
07 Mar 2023 //
EMA
Strides Pharma`s Approved Kauliv ( Teriparatide) In Europe
07 Mar 2023 //
EMA
Entera Bio Announces FDA Agreement for a Single Ph3 Trial NDA for EB613
06 Oct 2022 //
GLOBENEWSWIRE
Rani Therapeutics Announces Positive Topline Results from Ph1 Study of RT-102
10 Aug 2022 //
GLOBENEWSWIRE
Accord Healthcare Sondelbay (teriparatide) Receives Approval in Europe
16 Jun 2022 //
EMA
Grünenthal closes a deal with Teva to market teriparatide
18 Sep 2020 //
BORN2INVEST
Cadila Pharmaceuticals Announces Launch of Fourth Biosimilar in Two Months
28 Aug 2020 //
BIGMOLECULEWATCH
Strides re-enters injectable biz, to take controlling stake in Stelis Biopharma
20 Sep 2019 //
MONEYCONTROL
Richter launches Forsteo biosimilar in EU
22 Aug 2019 //
PHARMA TIMES
Richter Launched Terrosa®, its Biosimilar Teriparatide Across Europe
19 Aug 2019 //
PR NEWSWIRE
Amgen sets $21,900 annual price for new Evenity bone drug
17 Apr 2019 //
ENDPTS
Pfenex & Alvogen Expand Development, Commercialization Collaboration for PF708
28 Feb 2019 //
GLOBENEWSWIRE.COM/NEWS-RELEASE/2019/02/2
Hubert Chen resigns as Pfenex CMO ahead of NDA
18 Aug 2018 //
FIERCE PHARMA
Amgen, UCB pitch back once-rejected osteoporosis drug to the FDA
13 Jul 2018 //
ENDPTS